
Get exclusive money-saving offers and guides
Straight to your inbox
Posted
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Cronos Australia Limited is a drug manufacturers—specialty & generic business based in Australia. Cronos Australia shares (CAU) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Cronos Australia has a trailing 12-month revenue of around $123,850.
Our top pick for
US stocks
Our top pick for
Cheap broker fees
Our top pick for
Long-term investing
Since the stock market crash in March caused by coronavirus, Cronos Australia's share price has had significant negative movement.
Its last market close was $0.0855, which is 44.84% down on its pre-crash value of $0.155 and 14.00% up on the lowest point reached during the March crash when the shares fell as low as $0.075.
If you had bought $1,000 worth of Cronos Australia shares at the start of February 2020, those shares would have been worth $416.67 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $475.00.
52-week range | $0.07 - $0.415 |
---|---|
50-day moving average | $0.0846 |
200-day moving average | $0.0885 |
Target price | N/A |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | $-0.0699 |
Standard brokerage - Australian shares
Competitive broker fees on Australian and international shares
Important: Share trading carries risk of capital loss.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of A$0.0855 on 2020-10-22
1 week (2021-01-07) | -36.67% |
---|---|
1 month (2020-12-17) | -31.60% |
3 months (2020-10-16) | 11.04% |
6 months (2020-07-17) | 6.88% |
1 year (2020-01-16) | -59.29% |
---|---|
2 years (2019-01-13) | N/A |
3 years (2018-01-13) | N/A |
5 years (2016-01-13) | N/A |
Revenue TTM | $123,850 |
---|---|
Gross profit TTM | $116,786 |
Return on assets TTM | -28.52% |
Return on equity TTM | -74.54% |
Profit margin | 0% |
Book value | 0.104 |
Market capitalisation | $11.2 million |
TTM: trailing 12 months
We're not expecting Cronos Australia to pay a dividend over the next 12 months.
Cronos Australia Limited operates as a medicinal cannabis company in Australia and Asia. The company operates through Medicinal Cannabis and Clinics segments. It distributes PEACE NATURALS brand medicinal cannabis products; develops and sells medicinal cannabis products; and operates medicinal cannabis clinics. The company was incorporated in 2018 and is headquartered in South Yarra, Australia.
From the best RC plane for beginners to the top model for aerial photography, these are the six best RC planes in Australia right now.
Steps to owning and managing Vanguard Australian Fixed Interest Index ETF units.
Steps to owning and managing Vanguard Ethically Conscious Global Aggregate Bond Index (Hedged) ETF units.
Steps to owning and managing ETFS Morningstar Global Technology ETF units.
Steps to owning and managing BetaShares Global Quality Leaders (Currency Hedged) ETF units.
Steps to owning and managing ETFS ROBO Global Robotics and Automation ETF units.
Steps to owning and managing ETFS FANG+ ETF units.
Steps to owning and managing ETFS S&P Biotech ETF units.
Steps to owning and managing ETFS Reliance India Nifty 50 ETF units.
Steps to owning and managing BetaShares India Quality ETF units.